Failure in recycling cellular membrane may be a trigger of Parkinson's

February 23, 2017, Yale University
Failure in recycling cellular membrane may be a trigger of Parkinson’s
Immunofluorescence image of cultured neurons from mouse model of Parkinson’s disease shows abnormal accumulations of proteins at presynaptic nerve terminals making contact with the cell body of target neuron. Credit: Yale University

A genetic mutation found in patients with early-onset Parkinson's disease has been used to create a mouse model of the disease. The advance adds to growing evidence that—at least in a subset of patients—the neurodegenerative disorder may arise from the neuron's inability to efficiently recycle membranes of the packets that store and transport neurotransmitters.

A team led by Yale's Pietro De Camilli, a Howard Hughes Medical Institute researcher and professor of neuroscience and cell biology, wanted to assess the impact of a mutation in the synaptojanin 1 gene found in six patients who developed Parkinson's in their 20s and 30s. The work spearheaded by Mian Cao, a member of the De Camilli lab, recreated the patients' mutation in mice, which developed movement problems and epilepsy similar to the neurological problems found in Parkinson's.

Synaptojanin 1 plays a key role in the reformation of packets of neurotransmitters within the cell after neurotransmitters are released into the junction between neurons. This process, called endocytosis, is crucial to the fundamental function of the nervous system. However, defects were observed in neurons of a brain circuit involved in Parkinson's disease.

"It's very striking that several genes implicated in Parkinson's seem to be directly or indirectly related to endocytic function," De Camilli says. The study was published Feb. 22 in the journal Neuron.

Explore further: Discovery of genetic 'switch' could help to prevent symptoms of Parkinson's disease

More information: Mian Cao et al. Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons, Neuron (2017). DOI: 10.1016/j.neuron.2017.01.019

Related Stories

Discovery of genetic 'switch' could help to prevent symptoms of Parkinson's disease

February 17, 2017
A genetic 'switch' has been discovered by MRC researchers at the University of Leicester which could help to prevent or delay the symptoms of Parkinson's disease.

Mitochondrial lipids as potential targets in early onset Parkinson's disease

February 10, 2017
A team of researchers led by Patrik Verstreken (VIB–KU Leuven) have identified an underlying mechanism in early onset Parkinson's. Using flies, mice and patient cells, the team focused on cardiolipin, a fat unique to cells' ...

New light shed on causes of movement disorders Parkinson's disease

April 26, 2016
A possible cause has been found for the disrupted communication between brain cells exhibited by Parkinson's patients. Bettina Schwab, a researcher at the University of Twente, discovered that this group of patients have ...

New gene shown to cause Parkinson's disease

June 6, 2016
Northwestern Medicine scientists have discovered a new cause of Parkinson's disease—mutations in a gene called TMEM230. This appears to be the third gene definitively linked to confirmed cases of the common movement disorder.

Single mutation in recessive gene increases risk of earlier onset Parkinson's disease

November 2, 2016
A collaboration of 32 researchers in seven countries, led by scientists at Mayo Clinic's campus in Florida, has found a genetic mutation they say confers a risk for development of Parkinson's disease earlier than usual.

Breakthrough in understanding Parkinson's disease

August 29, 2016
Research from The University of Queensland could lead to a new treatment for Parkinson's disease, with future potential applications to nearly 50 other disorders.

Recommended for you

Protein levels in spinal fluid correlate to posture and gait difficulty in Parkinson's

February 21, 2018
Levels of a protein found in the brain called alpha-synuclein (α-syn) are significantly lower than normal in cerebrospinal fluid collected in Parkinson's disease patients suffering from postural instability and gait difficulty, ...

Calcium may play a role in the development of Parkinson's disease

February 19, 2018
Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson's disease.

New method maps the dopamine system in Parkinson's patients

February 14, 2018
With the aid of a PET camera, researchers from Karolinska Institutet in Sweden have developed a new method for investigating the dopamine system in the brains of patients suffering from Parkinson's disease. The method measures ...

Mechanism behind common Parkinson's mutation discovered

February 5, 2018
Northwestern Medicine investigators have discovered how a gene mutation results in buildup of a toxic compound known to cause Parkinson's disease symptoms, defining for the first time the mechanism underlying that aspect ...

Tactic for controlling motor symptoms of advanced Parkinson's disease

January 25, 2018
Standard drug treatment for Parkinson's disease can over time induce motor complications that reduce the effectiveness of restoring mobility. These complications include abnormal involuntary movements known as dyskinesias. ...

A new therapeutic avenue for Parkinson's disease

January 23, 2018
Systemic clearing of senescent astrocytes prevents Parkinson's neuropathology and associated symptoms in a mouse model of sporadic disease, the type implicated in 95% of human cases. Publishing in Cell Reports, researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.